Impact of FDA-Required Cardiovascular Outcome Trials on Type 2 Diabetes Clinical Study Initiation From 2008 to 2017
Therapeutic Innovation and Regulatory Science- United States
doi 10.1177/2168479019860122
Full Text
Abstract
Available in
Date
July 16, 2019
Authors
Publisher
Springer Science and Business Media LLC